{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:55:22Z","timestamp":1761411322984,"version":"build-2065373602"},"reference-count":85,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2003]]},"DOI":"10.1078\/1438-4221-00227","type":"journal-article","created":{"date-parts":[[2005,8,18]],"date-time":"2005-08-18T09:08:42Z","timestamp":1124356122000},"page":"441-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel vaccination strategies based on recombinant Mycobacterium bovis BCG"],"prefix":"10.1078","volume":"292","author":[{"given":"Guido","family":"Dietrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Viret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1078\/1438-4221-00227_bib1","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/13500872-141-7-1585","article-title":"Recombinant BCG expressing the Leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB\/c mice","volume":"141","author":"Abdelhak","year":"1995","journal-title":"Microbiology"},{"key":"10.1078\/1438-4221-00227_bib2","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/IAI.67.10.5100-5105.1999","article-title":"Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein","volume":"67","author":"Abomoelak","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/351479a0","article-title":"Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines","volume":"351","author":"Aldovini","year":"1991","journal-title":"Nature"},{"key":"10.1078\/1438-4221-00227_bib4","series-title":"Intracellular Bacterial Vaccine Vectors: Immunology, Cell Biology and Genetics","first-page":"151","article-title":"Recombinant BCG vaccines.","author":"Aldovini","year":"1999"},{"key":"10.1078\/1438-4221-00227_bib5","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1078\/1438-4221-00227_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"Belisle","year":"1997","journal-title":"Science"},{"key":"10.1078\/1438-4221-00227_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1126\/science.282.5389.759","article-title":"Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene","volume":"282","author":"Berthet","year":"1998","journal-title":"Science"},{"key":"10.1078\/1438-4221-00227_bib8","series-title":"Tuberculosis: Pathogenesis, Protection and Control.","first-page":"531","article-title":"The BCG experience: implications for future vaccines against tuberculosis.","author":"Bloom","year":"1994"},{"key":"10.1078\/1438-4221-00227_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0167-5699(92)90168-7","article-title":"A strategy to improve the efficacy of vaccination against tuberculosis and leprosy","volume":"13","author":"Bretscher","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1078\/1438-4221-00227_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"10.1078\/1438-4221-00227_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0966-842X(01)02131-X","article-title":"The evolution of mycobacterial pathogenicity: clues from comparative genomics","volume":"9","author":"Brosch","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1078\/1438-4221-00227_bib13","first-page":"201","article-title":"Sur la vaccination pr\u00e9ventive des enfants nouveau-n\u00e9s contre la tuberculose par le BCG","volume":"3","author":"Calmette","year":"1927","journal-title":"Ann. Inst. Pasteur."},{"key":"10.1078\/1438-4221-00227_bib14","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/IAI.68.12.7094-7099.2000","article-title":"Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin","volume":"68","author":"Chambers","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib15","first-page":"698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis","volume":"271","author":"Colditz","year":"1994","journal-title":"Meta-analysis of the published literature. JAMA"},{"key":"10.1078\/1438-4221-00227_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1078\/1438-4221-00227_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(99)00536-0","article-title":"Learning from the genome sequence of Mycobacterium tuberculosis H37Rv","volume":"452","author":"Cole","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1078\/1438-4221-00227_bib18","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase Gp63","volume":"90","author":"Connell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1286-4579(99)80077-X","article-title":"Cytolytic Tcell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin","volume":"1","author":"Conradt","year":"1999","journal-title":"Microbes Infect."},{"key":"10.1078\/1438-4221-00227_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF02307089","article-title":"Recombinant BCG therapy suppresses melanoma tumor growth","volume":"2","author":"Duda","year":"1995","journal-title":"Ann. Surg. Oncol."},{"key":"10.1078\/1438-4221-00227_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0264-410X(98)00276-X","article-title":"Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine","volume":"17","author":"Edelman","year":"1999","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-5347(05)68041-X","article-title":"Systemic and local immunomodulatory effects of intravesical BCG therapy in patients with superficial urinary bladder carcinomas","volume":"163","author":"Elsasser-Beile","year":"2000","journal-title":"J. Urol."},{"key":"10.1078\/1438-4221-00227_bib23","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/S0264-410X(00)00134-1","article-title":"Intranasal vaccination of mice against infection with Mycobacterium tuberculosis","volume":"18","author":"Falero-Diaz","year":"2000","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/172.3.698","article-title":"Recombinant bacille Calmette- Guerin priming against measles","volume":"172","author":"Fennelly","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1078\/1438-4221-00227_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/003655401300077144","article-title":"BCG: the challenge continues","volume":"33","author":"Fine","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"year":"1999","series-title":"Issues relating to the use of BCG in immunization programmes.","author":"Fine","key":"10.1078\/1438-4221-00227_bib26"},{"key":"10.1078\/1438-4221-00227_bib27","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.89.24.12013","article-title":"Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection","volume":"89","author":"Flynn","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0966-842X(01)02096-0","article-title":"Can a \u201cflawless\u201d live vector vaccine strain be engineered?","volume":"9","author":"Galen","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1078\/1438-4221-00227_bib29","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1128\/iai.62.10.4287-4295.1994","article-title":"Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen","volume":"62","author":"Gheorghiu","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib30","first-page":"200","article-title":"Biology of the mycobacterioses","volume":"154","author":"Good","year":"1968","journal-title":"Simian tuberculosis: immunologic aspects. Ann. N. Y. Acad. Sci."},{"key":"10.1078\/1438-4221-00227_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2958.1999.01383.x","article-title":"Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays","volume":"32","author":"Gordon","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1078\/1438-4221-00227_bib32","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4049\/jimmunol.168.4.1869","article-title":"Cell-mediated immunity induced by recombinant Mycobacterium bovis Bacille Calmette-Guerin strains against an intracellular bacterial pathogen: importance of antigen secretion or membrane-targeted antigen display as lipoprotein for vaccine efficacy","volume":"168","author":"Grode","year":"2002","journal-title":"J. Immunol."},{"key":"10.1078\/1438-4221-00227_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm0396-334","article-title":"Auxotrophic vaccines for tuberculosis","volume":"2","author":"Guleria","year":"1996","journal-title":"Nat. Med."},{"key":"10.1078\/1438-4221-00227_bib34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0264-410X(98)00350-8","article-title":"Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin","volume":"17","author":"Hayward","year":"1999","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib35","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib36","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0264-410X(00)00070-0","article-title":"Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: malE","volume":"18","author":"Himmelrich","year":"2000","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib37","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.1073\/pnas.92.23.10693","article-title":"Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals","volume":"92","author":"Honda","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib38","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30- kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib39","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis Proc","volume":"92","author":"Horwitz","year":"1995","journal-title":"Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib40","series-title":"Current Topics in Microbiology and Immunology 215 AD","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-3-642-80166-2_12","article-title":"BCG vaccination in the control of tuberculosis","author":"Huebner","year":"1996"},{"key":"10.1078\/1438-4221-00227_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.178.2.479","article-title":"Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo","volume":"178","author":"Inaba","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1078\/1438-4221-00227_bib42","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/S0264-410X(99)00550-2","article-title":"Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins","volume":"18","author":"Jabbar","year":"2000","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2958.1999.01549.x","article-title":"Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens","volume":"33","author":"Jungblut","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1078\/1438-4221-00227_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0264-410X(94)90054-X","article-title":"Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop","volume":"12","author":"Kameoka","year":"1994","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib45","series-title":"Fundamental Immunology.","first-page":"1335","article-title":"Immunity to intracellular bacteria.","author":"Kaufmann","year":"1998"},{"key":"10.1078\/1438-4221-00227_bib46","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1128\/IAI.66.12.5669-5676.1998","article-title":"Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from Schistosoma haematobium","volume":"66","author":"Kremer","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib47","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.4049\/jimmunol.156.11.4309","article-title":"Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guerin producing the Schistosoma mansoni glutathione Stransferase","volume":"156","author":"Kremer","year":"1996","journal-title":"J. Immunol."},{"key":"10.1078\/1438-4221-00227_bib48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/eji.1830250331","article-title":"Contribution of alpha\/beta and gamma\/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor-deficient mutant mice","volume":"25","author":"Ladel","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1078\/1438-4221-00227_bib49","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/jvi.71.3.2303-2309.1997","article-title":"Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T lymphocyte responses in mice","volume":"71","author":"Lagranderie","year":"1997","journal-title":"J. Virol."},{"key":"10.1078\/1438-4221-00227_bib50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0962-8479(93)90067-8","article-title":"BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route","volume":"74","author":"Lagranderie","year":"1993","journal-title":"Tuber. Lung. Dis."},{"key":"10.1078\/1438-4221-00227_bib51","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","article-title":"Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A","volume":"180","author":"Langermann","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1078\/1438-4221-00227_bib52","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/372552a0","article-title":"Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi","volume":"372","author":"Langermann","year":"1994","journal-title":"Nature"},{"key":"10.1078\/1438-4221-00227_bib53","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1073\/pnas.88.8.3111","article-title":"Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin","volume":"88","author":"Lee","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.1999.0131","article-title":"The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins","volume":"268","author":"Leung","year":"2000","journal-title":"Virology"},{"key":"10.1078\/1438-4221-00227_bib55","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1089\/aid.1997.13.1573","article-title":"Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs","volume":"13","author":"Lim","year":"1997","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1078\/1438-4221-00227_bib56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.2001.01428.x","article-title":"Recombinant bacille Calmette-Guerin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity","volume":"123","author":"Luo","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1078\/1438-4221-00227_bib57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent","volume":"178","author":"Mahairas","year":"1996","journal-title":"Mbovis. J. Bacteriol."},{"key":"10.1078\/1438-4221-00227_bib58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.188.5.845","article-title":"Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies","volume":"188","author":"Matsumoto","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1078\/1438-4221-00227_bib59","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/IAI.69.2.869-874.2001","article-title":"Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin","volume":"69","author":"Miyaji","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib60","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/IAI.70.4.2100-2107.2002","article-title":"Mycobacterial tuberculosis-infected mice","volume":"70","author":"Moreira","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib61","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1111\/j.1365-2958.1992.tb02201.x","article-title":"Expression of Escherichia coli beta-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses","volume":"6","author":"Murray","year":"1992","journal-title":"Mol. Microbiol."},{"key":"10.1078\/1438-4221-00227_bib62","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","article-title":"Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guerin strains that secrete cytokines","volume":"93","author":"Murray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib63","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib64","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4049\/jimmunol.166.1.447","article-title":"Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria","volume":"166","author":"Neyrolles","year":"2001","journal-title":"J. Immunol."},{"key":"10.1078\/1438-4221-00227_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0966-842X(98)01216-5","article-title":"Mechanisms of latency in Mycobacterium tuberculosis","volume":"6","author":"Parrish","year":"1998","journal-title":"Trends Microbiol."},{"key":"10.1078\/1438-4221-00227_bib66","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1073\/pnas.94.20.10955","article-title":"Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis","volume":"94","author":"Pelicic","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib67","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1078\/1438-4221-00227_bib68","first-page":"510","article-title":"Evaluation of tuberculosis control in the region of the former East Germany 1945\u20131990","volume":"53","author":"Scharkoff","year":"1991","journal-title":"\u00d6ffentl. Gesundheitswes."},{"key":"10.1078\/1438-4221-00227_bib69","first-page":"351","article-title":"Status and perspectives of preventive tuberculosis vaccination in East Germany 1990","volume":"84","author":"Schnorr","year":"1990","journal-title":"Z. \u00c4rztl. Fortbild."},{"key":"10.1078\/1438-4221-00227_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette- Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1078\/1438-4221-00227_bib71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1078\/1438-4221-00227_bib72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/expr.1999.4459","article-title":"BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice","volume":"94","author":"Streit","year":"2000","journal-title":"Exp. Parasitol."},{"key":"10.1078\/1438-4221-00227_bib73","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.96.10.5657","article-title":"Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection of the central nervous system","volume":"96","author":"Tsenova","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib74","first-page":"92","article-title":"Bacille Calmette-Guerin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferongamma (IFN-gamma)","volume":"199","author":"Wangoo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1078\/1438-4221-00227_bib75","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1078\/1438-4221-00227_bib76","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0264-410X(94)00001-4","article-title":"Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice","volume":"13","author":"Winter","year":"1995","journal-title":"Vaccine"},{"key":"10.1078\/1438-4221-00227_bib77","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-1119(91)90587-2","article-title":"Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein","volume":"109","author":"Winter","year":"1991","journal-title":"Gene"},{"key":"10.1078\/1438-4221-00227_bib78","unstructured":"World Health Organization. The World Health Report. 2001. World Health Organization, Geneva. 2001"},{"key":"10.1078\/1438-4221-00227_bib79","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(05)67417-4","article-title":"Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophagemediated cytotoxicity against murine bladder cancer MBT 2","volume":"164","author":"Yamada","year":"2000","journal-title":"J. Urol."},{"key":"10.1078\/1438-4221-00227_bib80","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.150.7.3101","article-title":"Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys","volume":"150","author":"Yasutomi","year":"1993","journal-title":"J. Immunol."},{"key":"10.1078\/1438-4221-00227_bib81","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1128\/jvi.69.4.2279-2284.1995","article-title":"A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cellfree simian immunodeficiency virus challenge","volume":"69","author":"Yasutomi","year":"1995","journal-title":"J. Virol."},{"key":"10.1078\/1438-4221-00227_bib82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.2000.0252","article-title":"Deletion of the 19-kDa antigen does not alter the protective efficacy of BCG","volume":"80","author":"Yeremeev","year":"2000","journal-title":"Tuber. Lung Dis."},{"key":"10.1078\/1438-4221-00227_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/83250","article-title":"A post-genomic perspective","volume":"7","author":"Young","year":"2001","journal-title":"Nat. Med."},{"key":"10.1078\/1438-4221-00227_bib84","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1073\/pnas.95.16.9578","article-title":"The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages","volume":"95","author":"Yuan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1078\/1438-4221-00227_bib85","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/514140","article-title":"Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia","volume":"176","author":"Zhu","year":"1997","journal-title":"J. Infect. Dis."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422104701216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422104701216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:51:58Z","timestamp":1761411118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422104701216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":85,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2003]]}},"alternative-id":["S1438422104701216"],"URL":"https:\/\/doi.org\/10.1078\/1438-4221-00227","relation":{},"ISSN":["1438-4221"],"issn-type":[{"type":"print","value":"1438-4221"}],"subject":[],"published":{"date-parts":[[2003]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel vaccination strategies based on recombinant Mycobacterium bovis BCG","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1078\/1438-4221-00227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Urban & Fischer Verlag. Published by Elsevier GmbH All rights reserved.","name":"copyright","label":"Copyright"}]}}